IMRT, IGRT, SBRT - Advances in the Treatment Planning and Delivery of Radiotherapy

Editor(s): Meyer, J.L. (San Francisco, CA)
Kavanagh, B.D. (Aurora, CO)
Purdy, J.A. (Sacramento, CA)
Timmerman, R. (Dallas, TX)

II. IMRT / IGRT Clinical Treatment Programs

Partial Breast Irradiation

Patient Selection, Guidelines for Treatment, and Current Results
Chen P.Y. ยท Vicini F.A.

Author affiliations

Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Mich. , USA

Related Articles for ""

Front Radiat Ther Oncol. Basel, Karger, 2007, vol. 40, pp 253-271

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of II. IMRT / IGRT Clinical Treatment Programs

Published online: July 13, 2007
Cover Date: 2007

Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-8199-8 (Print)
eISBN: 978-3-318-01415-0 (Online)

Abstract

Studies evaluating selected patients treated with partial breast irradiation (PBI) in accelerated fractionation schemes have demonstrated the equivalence of PBI with traditional whole-breast irradiation. The major advantage of PBI is the time compression of treatment down to less than 1 week compared with 6.5 weeks for whole-breast external beam treatments. Four techniques are available to deliver PBI. These include interstitial brachytherapy multicatheter systems, the Mammosite Radiation Therapy System applicator, external beam three-dimensional conformal radiation therapy and intraoperative radiation therapy. For the two brachytherapy techniques of multicatheter implantation and the Mammosite, accurate placement is achieved with image guidance via intraoperative ultrasonography, mammography, and/or CT scanning. Technologies such as image-guided cone beam CT assure accurate delivery of PBI with external beam three-dimensional conformal radiation therapy. Results of PBI show excellent control rates with mild toxicities; cosmetic outcomes are good to excellent in the vast majority of patients.




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of II. IMRT / IGRT Clinical Treatment Programs

Published online: July 13, 2007
Cover Date: 2007

Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-8199-8 (Print)
eISBN: 978-3-318-01415-0 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP